Related Experiment Videos
Testing for Causal Association Between Serum Urate, Gout, and Prostatic Cancer in European Males
Sumanth Chandrupatla1, Nicholas Sumpter2, Riku Takei1
1Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
Gout, Urate, and Crystal Deposition Disease
|August 6, 2026
Summary
Gout, specifically its non-hyperuricemia component, may causally influence prostate cancer risk in European men. Serum urate levels did not show a causal link to prostate cancer in this Mendelian randomization study.
Area of Science:
- Genetics
- Epidemiology
- Urology
Background:
- Gout and elevated serum urate (SU) are linked to inflammation.
- Prostate cancer is a common malignancy in men.
- The causal relationship between gout, SU, and prostate cancer remains unclear.
Purpose of the Study:
- To investigate the potential causal effects of serum urate and gout on prostate cancer risk.
- To explore the role of gout's non-hyperuricemia component in prostate cancer development.
- To examine potential reverse causality from prostate cancer to gout or SU.
Main Methods:
- A two-sample Mendelian randomization (MR) study using genome-wide association (GWAS) data from European men.
- Instrumental variables (IVs) were derived from single nucleotide polymorphisms (SNPs) for gout (including a non-hyperuricemia compartment) and serum urate.
- Standard MR methods (IVW, MR-Egger, weighted median) were employed to assess causal relationships and horizontal pleiotropy.
Main Results:
- The non-hyperuricemia compartment of gout showed a significant causal effect on increasing prostate cancer risk (weighted median p=0.01).
- Serum urate levels did not demonstrate a causal effect on prostate cancer risk (IVW p=0.83; weighted median p=0.97).
- MR-Egger regression indicated no significant horizontal pleiotropy for gout or urate IVs (p > 0.33).
- Genes IL1R1, IL1RN, and SLC30A5 were strongly associated with the non-hyperuricemia gout-prostate cancer link, suggesting an inflammatory pathway.
Conclusions:
- This MR study provides evidence for a causal link between the non-hyperuricemia component of gout and an increased risk of prostate cancer in European men.
- The findings implicate gout-associated inflammation, potentially involving IL1R1 and IL1RN, in prostate cancer pathogenesis.
- No causal effect was observed between serum urate levels and prostate cancer, nor reverse causality from prostate cancer to gout or SU.
Related Concept Videos
01:20Disorders of the Male Reproductive System
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
01:11Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...